356 related articles for article (PubMed ID: 10413735)
21. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State.
Frick PA; Black DJ; Duchin JS; Deliganis S; McKee WM; Fritsche TR
West J Med; 1998 Dec; 169(6):364-9. PubMed ID: 9866434
[TBL] [Abstract][Full Text] [Related]
22. [Antimicrobial susceptibility and serotype distribution of pneumococci strains isolated from meningitis patients].
Firat M; Ersoy Y; Eşel D; Bayraktar M; Caylan R; Durmaz R
Mikrobiyol Bul; 2006 Jul; 40(3):169-77. PubMed ID: 17001845
[TBL] [Abstract][Full Text] [Related]
23. Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.
Flamaing J; Verhaegen J; Vandeven J; Verbiest N; Peetermans WE
J Antimicrob Chemother; 2008 Jan; 61(1):143-9. PubMed ID: 17999974
[TBL] [Abstract][Full Text] [Related]
24. Widespread use of fluoroquinolones versus emerging resistance in pneumococci.
Goldstein EJ; Garabedian-Ruffalo SM
Clin Infect Dis; 2002 Dec; 35(12):1505-11. PubMed ID: 12471570
[TBL] [Abstract][Full Text] [Related]
25. A significant increase in antimicrobial resistance among pneumococci causing invasive disease in New Zealand.
Brett MS; Martin DR
N Z Med J; 1999 Apr; 112(1085):113-5. PubMed ID: 10326798
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic susceptibility of invasive Streptococcus pneumoniae in Wisconsin, 1999.
Belongia EA; Proctor M; Vandermause M; Ahrabi-Fard S; Knobloch MJ; Keller P; Bergs R; Chyou PH; Davis JP
WMJ; 2000 Aug; 99(5):55-9. PubMed ID: 11043072
[TBL] [Abstract][Full Text] [Related]
27. Pneumococci causing invasive disease in New Zealand, 1987-94: serogroup and serotype coverage and antibiotic resistances.
Martin DR; Brett MS
N Z Med J; 1996 Aug; 109(1027):288-90. PubMed ID: 8773670
[TBL] [Abstract][Full Text] [Related]
28. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
Farrell DJ; Klugman KP; Pichichero M
Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
[TBL] [Abstract][Full Text] [Related]
29. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
[TBL] [Abstract][Full Text] [Related]
30. Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage.
Pletz MW; van der Linden M; von Baum H; Duesberg CB; Klugman KP; Welte T;
Int J Med Microbiol; 2011 Jan; 301(1):53-7. PubMed ID: 20692869
[TBL] [Abstract][Full Text] [Related]
31. Serotype distribution and antimicrobial resistance patterns in Streptococcus pneumoniae isolates from hospitalized pediatric patients with respiratory infections in Shanghai, China.
Zhao GM; Black S; Shinefield H; Wang CQ; Zhang YH; Lin YZ; Lu JL; Guo YF; Jiang QW
Pediatr Infect Dis J; 2003 Aug; 22(8):739-42. PubMed ID: 12913778
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic susceptibility and serotypes of Streptococcus pneumoniae isolates from Hungary.
Dobay O; Rozgonyi F; Hajdú E; Nagy E; Knausz M; Amyes SG
J Antimicrob Chemother; 2003 Apr; 51(4):887-93. PubMed ID: 12654736
[TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
Adam HJ; Schurek KN; Decorby MR; Weshnoweski B; Vashisht R; Karlowsky K; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2006 Jul; 58(1):202-4. PubMed ID: 16636082
[TBL] [Abstract][Full Text] [Related]
34. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Rice CL; Doern GV
Clin Infect Dis; 2005 Jan; 40(2):225-35. PubMed ID: 15655739
[TBL] [Abstract][Full Text] [Related]
35. [Current data on the antibiotic sensitivity of Streptococcus pneumoniae (Pneumococcus). The significance of penicillin resistant isolates].
Reinert RR; Lütticken R; Kaufhold A
Med Klin (Munich); 1993 Jun; 88(6):357-61. PubMed ID: 8336662
[TBL] [Abstract][Full Text] [Related]
36. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
[TBL] [Abstract][Full Text] [Related]
37. In vitro susceptibility of six fluoroquinolones against invasive Streptococcus pneumoniae isolated from 1996 to 2001 in Taiwan.
Chen JY; Fung CP; Wang CC; Chu ML; Siu LK
Microb Drug Resist; 2003; 9(2):211-7. PubMed ID: 12820807
[TBL] [Abstract][Full Text] [Related]
38. Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates.
Pérez-Trallero E; Marimon JM; Iglesias L; Larruskain J
Emerg Infect Dis; 2003 Sep; 9(9):1159-62. PubMed ID: 14519256
[TBL] [Abstract][Full Text] [Related]
39. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci.
Pallares R; Gudiol F; Liñares J; Ariza J; Rufi G; Murgui L; Dorca J; Viladrich PF
N Engl J Med; 1987 Jul; 317(1):18-22. PubMed ID: 3587309
[TBL] [Abstract][Full Text] [Related]
40. Fluoroquinolone-resistant Streptococcus pneumoniae.
Pletz MW; Fugit RV; McGee L; Glasheen JJ; Keller DL; Welte T; Klugman KP
Emerg Infect Dis; 2006 Sep; 12(9):1462-3. PubMed ID: 17073107
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
